Literature DB >> 2222860

Detection of cathepsin B, plasminogen activators and plasminogen activator inhibitor in human non-small lung cancer cell lines.

G Trefz1, M Erdel, E Spiess, W Ebert.   

Abstract

Human non-small lung cancer cell lines HS-24 (established from a primary squamous cell carcinoma) and SB-3 (established from a metastasis of a primary adenocarcinoma of the lung into the adrenal gland) were analysed for the proteinases tissue-type plasminogen activator (tPA), urokinase-type plasminogen activator inhibitor (PAI-1). The proteinases were characterized by activity measurements, inhibition studies, enzyme-linked immunosorbent assay (ELISA), and Western blot analysis. Cell-associated proteinases were determined in cell lysates, secreted proteinases in cell conditioned culture media. Both cell lines were found to secrete uPA and PAI-1, whereas tPA could be detected only in HS-24 conditioned media. No cathepsin B activity could be detected in media of both cell lines. However, activation experiments and western blot analysis showed, that at least HS-24 secrete an inactive precursor. Cell lysates of HS-24 and SB-3 show PA activity, but on a low level. Cathepsin B activity was also found to be low in HS-24 lysates. However, SB-3 lysates show high cathepsin B activity. Further characterization of the proteinases by their sensitivity against several inhibitors suggests that they are similar to the corresponding proteinases of normal, nonmalignant cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2222860     DOI: 10.1515/bchm3.1990.371.2.617

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  2 in total

1.  Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma.

Authors:  A Sedo; E Krepela; E Kasafírek
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Immunohistochemical analysis of cathepsin B expression in human lung adenocarcinoma: the role in cancer progression.

Authors:  Y Ozeki; K Takishima; K Takagi; S Aida; S Tamai; G Mamiya; T Ogata
Journal:  Jpn J Cancer Res       Date:  1993-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.